AESKULSKA BETA2-GLYCO-A— 510(k) K062217

Substantially Equivalent

Aesku, Inc.

FDA 510(k) clearance K062217 for AESKULSKA BETA2-GLYCO-A, Substantially Equivalent on 2006-12-13. Applicant: Aesku, Inc..

Clearance details

Applicant: Aesku, Inc.
Product code: Code MSV
Advisory panel: Immunology
Date received: 2006-08-01
Decision date: 2006-12-13
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Miami, FL, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.